This study is the first to discuss BCL9 CNV in HCC Egyptian patients; it recorded that there is gain in BCL9 CNV in 14% of HCC patients and also showed that CN gains existed only in male patients. This evidence concerns the gene BCL9 and hepatocellular carcinoma.